These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32073411)

  • 21. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.
    Vaisman BL; Neufeld EB; Freeman LA; Gordon SM; Sampson ML; Pryor M; Hillman E; Axley MJ; Karathanasis SK; Remaley AT
    J Pharmacol Exp Ther; 2019 Mar; 368(3):423-434. PubMed ID: 30563940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of circulating lipoprotein profile and proteinuria in a patient with LCAT deficiency due to a novel mutation (Cys74Tyr) in the lid region of LCAT under a fat-restricted diet and ARB treatment.
    Naito S; Kamata M; Furuya M; Hayashi M; Kuroda M; Bujo H; Kamata K
    Atherosclerosis; 2013 May; 228(1):193-7. PubMed ID: 23522979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel pathogenic variant in LCAT causing FLD. A case report.
    Goñi Ros N; González-Tarancón R; Sienes Bailo P; Salvador-Ruperez E; Puzo Bayod M; Puzo Foncillas J
    Acta Clin Belg; 2022 Dec; 77(6):970-975. PubMed ID: 34789074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans.
    Pavanello C; Ossoli A; Strazzella A; Risè P; Veglia F; Lhomme M; Parini P; Calabresi L
    J Lipid Res; 2022 Jul; 63(7):100232. PubMed ID: 35598637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
    Manthei KA; Yang SM; Baljinnyam B; Chang L; Glukhova A; Yuan W; Freeman LA; Maloney DJ; Schwendeman A; Remaley AT; Jadhav A; Tesmer JJ
    Elife; 2018 Nov; 7():. PubMed ID: 30479275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.
    Roshan B; Ganda OP; Desilva R; Ganim RB; Ward E; Haessler SD; Polisecki EY; Asztalos BF; Schaefer EJ
    J Clin Lipidol; 2011; 5(6):493-9. PubMed ID: 22108153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.
    Calabresi L; Baldassarre D; Castelnuovo S; Conca P; Bocchi L; Candini C; Frigerio B; Amato M; Sirtori CR; Alessandrini P; Arca M; Boscutti G; Cattin L; Gesualdo L; Sampietro T; Vaudo G; Veglia F; Calandra S; Franceschini G
    Circulation; 2009 Aug; 120(7):628-35. PubMed ID: 19687369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
    Baass A; Wassef H; Tremblay M; Bernier L; Dufour R; Davignon J
    Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant lecithin:cholesterol acyltransferase containing a Thr123-->Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein.
    O K; Hill JS; Wang X; Pritchard PH
    J Lipid Res; 1993 Jan; 34(1):81-8. PubMed ID: 8445345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator Compound.
    Pavanello C; Ossoli A; Turri M; Strazzella A; Simonelli S; Laurenzi T; Kono K; Yamada K; Kiyosawa N; Eberini I; Calabresi L
    J Pharmacol Exp Ther; 2020 Dec; 375(3):463-468. PubMed ID: 32980814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.
    Savel J; Lafitte M; Pucheu Y; Pradeau V; Tabarin A; Couffinhal T
    Vasc Health Risk Manag; 2012; 8():357-61. PubMed ID: 22701329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review.
    Shoji K; Morita H; Ishigaki Y; Rivard CJ; Takayasu M; Nakayama K; Nakayama T; Inoue Y; Ayaki M; Yoshimura A
    Clin Nephrol; 2011 Oct; 76(4):323-8. PubMed ID: 21955868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the structure of the gene for lecithin: cholesterol acyltransferase in four unrelated individuals with familial lecithin: cholesterol acyltransferase deficiency.
    Humphries SE; Chaves ME; Tata F; Lima VL; Owen JS; Borysiewicz LK; Catapano A; Vergani C; Gjone E; Clemens MR
    Clin Sci (Lond); 1988 Jan; 74(1):91-6. PubMed ID: 3338256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein X Causes Renal Disease in LCAT Deficiency.
    Ossoli A; Neufeld EB; Thacker SG; Vaisman B; Pryor M; Freeman LA; Brantner CA; Baranova I; Francone NO; Demosky SJ; Vitali C; Locatelli M; Abbate M; Zoja C; Franceschini G; Calabresi L; Remaley AT
    PLoS One; 2016; 11(2):e0150083. PubMed ID: 26919698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.
    Dobiásová M; Frohlich JJ
    Clin Chim Acta; 1999 Aug; 286(1-2):257-71. PubMed ID: 10511297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase.
    Holleboom AG; Kuivenhoven JA; van Olden CC; Peter J; Schimmel AW; Levels JH; Valentijn RM; Vos P; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Hollak CE
    Atherosclerosis; 2011 May; 216(1):161-5. PubMed ID: 21315357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase.
    Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
    J Lipid Res; 1995 May; 36(5):967-74. PubMed ID: 7658168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings.
    Norum KR; Remaley AT; Miettinen HE; Strøm EH; Balbo BEP; Sampaio CATL; Wiig I; Kuivenhoven JA; Calabresi L; Tesmer JJ; Zhou M; Ng DS; Skeie B; Karathanasis SK; Manthei KA; Retterstøl K
    J Lipid Res; 2020 Aug; 61(8):1142-1149. PubMed ID: 32482717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.